ArdorComm Media Group

Contact Us
Tuesday, August 19, 2025 1:15 PM
logo
Menu
logo

Health & Wellness Community

AIIMS and Wipro GE Healthcare Join Forces to Launch AI Health Innovations Hub

Leave a Comment / / Health & Wellness Community

In a landmark initiative aimed at transforming the landscape of Indian healthcare, the All India Institute of Medical Sciences (AIIMS), New Delhi, has signed a Memorandum of Understanding (MoU) with Wipro GE Healthcare Pvt. Ltd. to set up an AI Health Innovations Hub. This collaborative center will focus on the development of cutting-edge medical technologies that promise to enhance diagnostics, treatment protocols, and real-time patient care. The AI Health Innovations Hub will harness artificial intelligence to co-develop and test intelligent systems across critical domains such as cardiology, oncology, and neurology. Wipro GE Healthcare, the technology partner, will invest approximately $1 million over five years to build and deploy AI-powered workflow solutions. AIIMS, acting as the clinical partner, will provide access to a real-world hospital environment and offer expert clinical input, feedback, and validation for these technologies. A joint working committee comprising representatives from both organizations will guide the initiative, which will also incorporate academic research and knowledge exchange. This partnership is seen as a strategic step in accelerating the development of advanced medical technologies within India. Dr. M. Srinivas, Director of AIIMS, highlighted the significance of the collaboration, stating, “This partnership holds immense strategic value and aligns with the national vision of Viksit Bharat through advanced healthcare. We are confident that this collaboration will fast-track MedTech innovation and deliver better outcomes for patients.” The initiative marks a significant step towards integrating AI-driven solutions in mainstream healthcare, paving the way for smarter, more efficient, and inclusive healthcare systems in India. Source: The Hindu

AIIMS and Wipro GE Healthcare Join Forces to Launch AI Health Innovations Hub Read More »

Yeshasvini Health Scheme Set for Major Rate Hike: Committee Recommends 50% Increase for Complex Procedures

Leave a Comment / / Health & Wellness Community

In a significant development aimed at strengthening Karnataka’s flagship Yeshasvini health scheme, a government-appointed expert committee has recommended a revision of treatment rates—up to 50% for certain complex medical procedures. This long-awaited move is expected to encourage greater participation from private hospitals and improve access to quality care for lakhs of beneficiaries. The committee, chaired by Kudligi MLA and ophthalmologist Dr. Srinivas N.T., submitted its findings to Chief Minister Siddaramaiah on Tuesday. The report suggests a standard rate hike of 15% to 25% for most of the 2,128 existing procedures, while recommending a substantial 50% increase for high-end procedures such as paediatric heart surgeries, oncology, neuro-surgery, and interventional radiology. First launched in 2003, the Yeshasvini scheme is one of India’s largest self-funded healthcare models. Merged under the Arogya Karnataka umbrella in 2018 and reintroduced in 2022-2023 due to public demand, the scheme allows rural families to access cashless treatment up to ₹5 lakh annually with a nominal contribution of ₹500. Urban families pay ₹1,000 for the same benefits. Over 45.6 lakh cooperative society members are currently enrolled. The committee met 13 times over six months, consulting top doctors and health industry experts to assess current market trends. As a result, six outdated procedures have been dropped and 69 new ones added, bringing the total to 2,191. Dr. Srinivas noted that outdated pricing deterred many private hospitals from participating. Currently, 782 hospitals are empanelled, and the revisions could potentially increase this number. In 2024-2025, 68,159 beneficiaries were treated at a cost of ₹117.79 crore. With the projected rise in treatments and expanded coverage, the committee has requested an additional ₹40 crore in government funding to support the revamped scheme. Source: The Hindu

Yeshasvini Health Scheme Set for Major Rate Hike: Committee Recommends 50% Increase for Complex Procedures Read More »

Affordable, Quality Healthcare Remains Key Focus of Central Government: JP Nadda

Leave a Comment / / Health & Wellness Community

Union Health Minister J.P. Nadda reaffirmed the central government’s unwavering commitment to ensuring affordable and quality healthcare for every underprivileged citizen in India. Speaking during a session titled “Promoting Swasth Bharat through Ayushman Bharat PM Jan Arogya Yojana and Ayushman Arogya Mandir” at the Civil Services Day celebrations, Mr. Nadda emphasized that accessible healthcare is not just a goal but a national priority. Highlighting the strides made over the last decade, Mr. Nadda revealed that the government’s expenditure on healthcare has increased significantly—from 29 percent in 2014 to 48 percent today. This boost has resulted in a notable reduction in the financial burden on citizens seeking medical care, particularly in out-of-pocket expenses. He also noted the role of Ayushman Arogya Mandirs in early screening and preventive care, particularly for communicable and non-communicable diseases. These centers have expanded their service packages, further supporting a health-first approach and enhancing public health outcomes across the country. Health facilities, he said, are being encouraged to undertake self-assessment through the Indian Public Health Standards (IPHS) 2022 and the National Quality Assurance Standards (NQAS) frameworks, ensuring continual improvement in service delivery. Adding to the discussion, Dr. V.K. Paul, Member (Health), NITI Aayog, pointed out that the implementation of Ayushman Bharat PM-JAY has resulted in a drop in out-of-pocket healthcare expenditure from 64 percent in 2013-14 to 39.4 percent in 2021-22—a milestone in making healthcare more financially accessible. The session underscored the government’s vision for a Swasth Bharat, driven by preventive care, financial protection, and quality assurance. Source: News on Air

Affordable, Quality Healthcare Remains Key Focus of Central Government: JP Nadda Read More »

Maharashtra Announces ₹1 Lakh Cashless Treatment for All Accident Victims

Leave a Comment / / Health & Wellness Community

In a major public healthcare reform, Maharashtra’s Public Health Minister Prakash Abitkar announced on Friday that all accident victims across the state will now be eligible for cashless medical treatment of up to ₹1 lakh—regardless of their enrolment in any government health schemes. The announcement came during a review meeting held at the State Health Guarantee Society’s headquarters in Worli. Present at the meeting were CEO of the Society Annasaheb Chavan, Ayushman Bharat Mission Maharashtra Committee Chairman Dr Omprakash Shete, and other senior health department officials. Abitkar emphasized the urgency of immediate medical intervention following accidents, stating that financial constraints should never hinder critical care. “Victims often don’t carry money during emergencies. This move ensures timely treatment without financial delays,” he said, directing officials to swiftly implement the initiative. To ensure better accessibility, the state will increase the number of empanelled private hospitals from 1,792 to 4,180, with selection supervised by district collectors. A mobile app is also under development to provide real-time hospital data, including bed availability and grievance redressal. Further, a dedicated study committee will explore expanding treatment coverage under government schemes, including high-cost procedures like organ transplants. The panel will review treatment costs and assess the inclusion of primary healthcare services, with a report due in a month. In a community-focused approach, empanelled hospitals must host one free health camp monthly and offer cashless treatment to at least five patients. Public representatives will support these initiatives. To boost Ayushman Bharat card distribution, the government will involve ASHA workers, Anganwadi staff, ration shopkeepers, and civic centres—along with a proposed increase in their honorariums for supporting the campaign. Source: Hindustan Times

Maharashtra Announces ₹1 Lakh Cashless Treatment for All Accident Victims Read More »

Three Million Child Deaths Linked to Drug Resistance: A Global Health Crisis

Leave a Comment / / Health & Wellness Community

A recent global study has sounded alarm bells over the escalating threat of antimicrobial resistance (AMR), revealing that 3 million child deaths in 2022 were linked to infections no longer responding to standard antibiotics. The report, compiled by the Murdoch Children’s Research Institute (Australia) and the Clinton Health Access Initiative, highlights how AMR is fast becoming a global health crisis—particularly affecting children in Africa and Southeast Asia. AMR occurs when bacteria, viruses, or fungi evolve to resist the effects of medicines that once worked against them. As a result, common infections become harder—and sometimes impossible—to treat. This “silent pandemic” has been aggravated by the overuse and misuse of antibiotics, especially in countries like India, which has been flagged as a hotspot due to regulatory gaps and easy access to drugs. Key findings include: 3 million global child deaths in 2022 were AMR-related. 752,000 child deaths occurred in Southeast Asia, and 659,000 in Africa. Use of ‘watch antibiotics’ (for serious infections) rose by 126% in Africa and 160% in Southeast Asia from 2019 to 2021. Use of ‘reserve antibiotics’ (last-resort drugs) increased by 125% and 45%, respectively. The study attributes the rise to overcrowded hospitals, poor sanitation, lack of diagnostic access, and weak antimicrobial stewardship. It also underscores the slow pace of new antibiotic development, which further reduces treatment options for resistant infections. Experts recommend a “One Health” approach, integrating data on how infections spread among humans, animals, and the environment. They also urge stronger national policies, hospital-level antibiotic regulation, and the use of real-time health data to guide responsible treatment decisions. With the World Health Organization already warning about AMR’s impact on mortality and health systems, the report stresses that immediate action is critical to prevent a catastrophic rise in untreatable infections among the most vulnerable—our children. Source: Indiatoday

Three Million Child Deaths Linked to Drug Resistance: A Global Health Crisis Read More »

India Plans Major HPV Vaccine Push with Frontline Training and Awareness Drive

Leave a Comment / / Health & Wellness Community

The Union Health Ministry is set to launch comprehensive capacity-building initiatives for frontline workers involved in administering the Human Papillomavirus (HPV) vaccine, as part of its ongoing efforts to prevent cervical cancer among young girls. This follows Union Finance Minister Nirmala Sitharaman’s announcement in the 2024 interim budget encouraging HPV vaccination for girls aged 9–14. Sources indicate that multiple meetings have been held by the ministry to devise a detailed strategy for the rollout. “Capacity building for frontline health workers, along with sensitization through IEC (Information, Education, and Communication) activities, is being planned for smooth implementation of the HPV vaccination program,” a senior official confirmed. The National Technical Advisory Group on Immunisation (NTAGI) had recommended the inclusion of the HPV vaccine in India’s Universal Immunisation Programme in June 2022. Currently, India has access to vaccines from MSD Pharmaceuticals and Serum Institute of India. MSD’s Gardasil 4 and Serum Institute’s Cervavac target four HPV sub-types: 6, 11, 16, and 18. Gardasil 9 — India’s first gender-neutral HPV vaccine — offers protection against nine HPV sub-types and is available for girls (9–26 years) and boys (9–15 years). The vaccines provide protection against cervical, vulvar, vaginal, and anal cancers, as well as genital warts in both males and females. Sub-types 16 and 18 are the leading causes of cervical cancer, officials noted. The World Health Organization (WHO) recommends a single-dose vaccine for optimal protection. India, home to 16% of the world’s women, accounts for nearly 25% of global cervical cancer cases and 33% of related deaths. Each year, around 80,000 Indian women are diagnosed with cervical cancer, and approximately 35,000 succumb to the disease. Source: Business Standard

India Plans Major HPV Vaccine Push with Frontline Training and Awareness Drive Read More »

Health Ministry Releases National Guidelines on Medical Oxygen Management

Leave a Comment / / Health & Wellness Community

The Union Health Ministry has released the National Guidelines on Medical Oxygen Management, underscoring the critical importance of maintaining and utilizing medical oxygen infrastructure in healthcare facilities. The announcement was made at a workshop held at AIIMS Delhi, where Health Secretary Punya Salila Srivastava emphasized the need for efficient oxygen management to enhance clinical outcomes and emergency preparedness. The event also marked the launch of the National Capacity Building Programme on Oxygen Management, which aims to train 200 master trainers. These trainers will help hospital administrators and medical officers across India improve oxygen handling, reduce wastage, and optimize usage. Key Highlights of the Initiative: The National Guidelines provide a structured framework for the procurement, storage, and administration of medical oxygen. AIIMS Delhi will spearhead the capacity-building program, ensuring training at all levels of healthcare. The initiative, led by the Disaster Management Cell of the Ministry of Health and Family Welfare, is focused on patient safety, infrastructure preparedness, and best practices in oxygen management. Learnings from India’s COVID-19 response have been incorporated into the guidelines to strengthen future pandemic readiness. Addressing the gathering, Dr. M. Srinivas, Director of AIIMS, stressed the importance of awareness and training to ensure optimal oxygen management. The standardized guidelines are expected to enhance India’s healthcare resilience, ensuring hospitals nationwide are better equipped to handle medical oxygen needs during emergencies. Source: Business Standard

Health Ministry Releases National Guidelines on Medical Oxygen Management Read More »

Gennova Biopharma Partners with CEPI to Develop mRNA Nipah Vaccine

Leave a Comment / / Health & Wellness Community

Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals, has announced a partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a self-amplifying mRNA (saRNA) vaccine for the Nipah virus. The collaboration has secured up to $13.38 million in funding from CEPI to accelerate research and development. Innovative Approach to Vaccine Development As part of this initiative, Gennova will work with the Houston Methodist Research Institute (HMRI), a CEPI partner based in the United States, to integrate artificial intelligence (AI) into vaccine design. AI-driven analysis will be used to identify optimal vaccine targets, enhancing immune response efficiency. Clinical trials are set to begin in India, where Nipah outbreaks have previously occurred. The Nipah Virus Threat Nipah virus, a highly lethal pathogen from the Paramyxovirus family, has caused multiple outbreaks in South and Southeast Asia, with a fatality rate of up to 75%. Though outbreaks have been geographically limited, the virus’s natural reservoir—fruit bats—inhabits regions home to over two billion people, making it a serious global health concern. CEPI’s Commitment to Global Health Kent Kester, Executive Director of Vaccine R&D at CEPI, emphasized the urgency of the project, stating: “With no approved vaccines or specific treatments for Nipah, CEPI is leading the global effort to develop countermeasures. Gennova’s saRNA technology could not only help fight Nipah but also enhance pandemic preparedness, enabling rapid responses within 100 days of identifying a new viral threat.” The Advantage of saRNA Vaccines Unlike traditional mRNA vaccines, which introduce pre-made antigenic proteins, saRNA vaccines provide genetic instructions that enable the body’s own cells to produce these proteins. This approach enhances the immune response while requiring lower doses, making it a promising platform for future vaccine development. A Long-Term Collaboration Gennova’s partnership with CEPI is not new. In August 2023, CEPI granted the company $3.6 million to optimize its saRNA technology for developing vaccines against unknown pathogenic threats, often referred to as Disease X. Sanjay Singh, CEO of Gennova Biopharmaceuticals, commented on the collaboration: “By harnessing our saRNA platform, we aim to develop a next-generation Nipah vaccine. This partnership sets a new benchmark for rapid vaccine development while ensuring equitable access and strengthening global health security.” Ensuring Equitable Access CEPI has invested over $100 million in Nipah vaccine research. Through this collaboration, Gennova has pledged to uphold CEPI’s Equitable Access Policy, ensuring that the vaccine, if successfully developed, will be made available first to at-risk populations at an affordable price. The agreement also includes provisions for technology transfer, which could support future vaccine development efforts against emerging infectious diseases.

Gennova Biopharma Partners with CEPI to Develop mRNA Nipah Vaccine Read More »

Aster MIMS Becomes India’s First Hospital to Receive AHA’s Comprehensive Stroke Center Accreditation

Leave a Comment / / Health & Wellness Community

Aster MIMS, Kozhikode, has made history by becoming the first hospital in India to receive the prestigious Comprehensive Stroke Center accreditation from the American Heart Association (AHA). This global recognition highlights the hospital’s excellence in stroke care, encompassing advanced diagnostics, cutting-edge treatment, and comprehensive rehabilitation. Aster MIMS follows an integrated stroke care model, beginning at the pre-hospital stage with its innovative Response-Rescue-Resuscitation (R-R-R) system. The hospital also boasts one of South Asia’s first emergency department Biplane Cathlabs, enabling precise stroke diagnosis and rapid intervention. Lukman Ponmadath, COO of Aster MIMS, remarked, “This accreditation is a testament to our commitment to delivering world-class stroke treatment. It highlights our advanced diagnostics, modern therapies, and comprehensive post-stroke care, ensuring timely and effective treatment.” The hospital has already garnered multiple accolades in stroke management, including: World Stroke Organization’s Angels Awards (9 Diamond, 2 Platinum, 3 Gold) IHWS Patient-Centric Hospital in Stroke Care Award Voice of Healthcare’s Stroke Innovation and Excellence Award Dr. Venugopalan P P, Head of Emergency Medicine, emphasized the hospital’s commitment, stating, “With our state-of-the-art infrastructure, we ensure timely interventions that significantly improve recovery outcomes.” The hospital’s R-R-R system facilitates seamless communication between emergency teams, enabling real-time assessments and critical interventions even before patients arrive. Its Biplane Cathlab ensures immediate imaging and precise treatment, significantly reducing Door-to-Needle Time (DTNT) and Door-to-Groin Time (DTGT)—crucial for better patient outcomes. The achievement was formally announced at a press conference attended by key officials, including Lukman Ponmadath, Dr. Jacob Alappat, Dr. Abraham Mammen, Dr. Noufal Basheer, Dr. Venugopalan P P, Dr. Abdul Rahman, Dr. Rafeeque, and Dr. Paul Alappat. Source: daijiworld

Aster MIMS Becomes India’s First Hospital to Receive AHA’s Comprehensive Stroke Center Accreditation Read More »

CDC Retracts $11.4B in Covid Funds, Sparking Concerns Among Health Departments

Leave a Comment / / Health & Wellness Community

The Centers for Disease Control and Prevention (CDC) is withdrawing $11.4 billion in Covid-related funding from state and community health departments, NGOs, and international recipients, the Department of Health and Human Services (HHS) confirmed Tuesday. HHS Communications Director Andrew Nixon stated, “The COVID-19 pandemic is over, and HHS will no longer waste billions of taxpayer dollars responding to a non-existent pandemic. We are shifting focus to tackling chronic diseases and making America healthy again.” The funding retraction notices were sent Monday, giving recipients 30 days to reconcile expenditures. The affected grants primarily covered: Covid testing & vaccination Community health workers Health disparity initiatives for minority & rural populations Global Covid projects Wider Impact on Public Health While the federal public health emergency ended in May 2023, concerns remain over long Covid and ongoing infections, with hundreds of deaths still reported weekly. Health officials fear the cuts may undermine broader public health efforts. Kristina Iodice, spokesperson for Colorado’s Department of Public Health, warned the loss of funding could hamper outbreak response, disease tracking, and immunization efforts. Several state health departments confirmed receipt of the withdrawal notice, including Mississippi, Utah, and nine others. Officials in Texas and Florida were hit hardest, with $877 million and $482 million in grants canceled, respectively. HHS Budget Cuts Under New Leadership Under HHS Secretary Robert F. Kennedy Jr., the department has also canceled funding for: Vaccine hesitancy research LGBTQ+ health initiatives HIV prevention programs The CDC reviewed its Covid-related grants and determined which were no longer necessary, though a full list of rescinded projects has not been made public. As federal health funding undergoes a major shift, state agencies are now scrambling to assess the long-term effects of these sudden budget cuts. Source: NBC

CDC Retracts $11.4B in Covid Funds, Sparking Concerns Among Health Departments Read More »